Noveris Health Sciences

Noveris is a biotechnology company focused on monitoring genomic stability and cellular aging through advanced telomere profiling. Spun out from the Salk Institute for Biological Studies, the company leverages proprietary technology to measure telomere length and distribution as a critical biomarker for cancer and age-related diseases. Their platform provides high-resolution data that offers a more comprehensive view of cellular health than traditional average telomere length measurements. By identifying the shortest telomeres, which are primary drivers of genomic instability, Noveris aims to enable early disease detection and personalized treatment strategies. The company's mission is to transform telomere science into actionable clinical insights for oncology and longevity.